For the study ... show. The findings were published Monday in the Annals of Internal Medicine. There has been a notable uptick in GLP-1 use since 2020, Rezaie noted. The U.S. Food and Drug ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Fact checked by Jennifer Klump GLP-1 drugs may increase the risk of a severe form of macular degeneration in older adults ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs GLP-1 medications show promise in slowing ... GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

For this study, researchers analyzed U.S. federal research data in which people were asked about their GLP-1 prescriptions. Results showed that among people without diabetes, GLP-1 drug use rose ...

"This large cohort study represents a reassuring safety signal showing that GLP-1 drugs are not ... links between GLP-1 use and pancreatic cancer. And this just shows, as have other human studies ...

BARCELONA -- A rheumatology trainee who went on TikTok to find information on her own condition may have uncovered a novel ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat ... said that “this study was helpful to show that some muscle can occur with significant ...